Detalhe da pesquisa
1.
Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
J Cell Physiol
; 230(6): 1298-309, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469885
2.
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Glycobiology
; 24(10): 899-906, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24939371
3.
Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
IUBMB Life
; 62(1): 1-13, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20014236
4.
In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.
Clin Cancer Res
; 23(17): 5135-5148, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512172
5.
Study of galectins in tumor immunity: strategies and methods.
Methods Mol Biol
; 1207: 249-68, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253145
6.
Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.
Methods Mol Biol
; 1207: 293-304, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253148
7.
Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.
Prostate Cancer
; 2013: 519436, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24205440
8.
Delineating the "galectin signature" of the tumor microenvironment.
Oncoimmunology
; 2(4): e23565, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23734312
9.
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Cancer Res
; 73(1): 86-96, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108139
10.
TSLP1: a new piece in the puzzle of tumor-associated Th2-type inflammation.
Immunotherapy
; 3(6): 713-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21668306